» Articles » PMID: 9881259

CT-guided Percutaneous Treatment of Inoperable Pulmonary Aspergillomas: a Study of 40 Cases

Overview
Journal Eur J Radiol
Specialty Radiology
Date 1999 Jan 9
PMID 9881259
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To treat symptomatic pulmonary aspergilloma in patients who were not considered to be operable.

Material And Methods: Forty patients were treated by CT-guided percutaneous injection of amphotericin paste, the aim being to fill the cavity completely and create an anaerobic environment for the aspergillus. The aspergillomas had developed after bacillary infection and pulmonary fibrosis. Surgery was contra-indicated in these patients because of severe respiratory failure. The authors detail the method of preparation of the paste and the technique of percutaneous injection.

Results: Hemoptysis ceased in all 40 patients, with a follow-up ranging from 6 to 28 months; six patients were also treated with bronchial embolization. In 26 patients, the aspergilloma disappeared and serum tests for aspergillus became negative. Complete disappearance of both the aspergilloma and the cavity was obtained in three patients.

Conclusion: This technique appears to be a valuable contribution to non-surgical treatment of inoperable patients with pulmonary aspergilloma, but study should be continued in a larger series to define the exact indications and the interaction with other treatments which have recently been introduced.

Citing Articles

Imaging of thoracic tuberculosis: pulmonary and extrapulmonary.

Pattamapaspong N, Kanthawang T, Peh W, Hammami N, Bouaziz M, Ladeb M BJR Open. 2024; 6(1):tzae031.

PMID: 39363908 PMC: 11449295. DOI: 10.1093/bjro/tzae031.


Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges.

Tashiro M, Takazono T, Izumikawa K Ther Adv Infect Dis. 2024; 11:20499361241253751.

PMID: 38899061 PMC: 11186400. DOI: 10.1177/20499361241253751.


Endobronchial amphotericin B to treat hemoptysis in an inoperable patient with aspergillosis.

Pinto M, Rodrigues J, Silva M, Maia D, Miguel A Med Mycol Case Rep. 2024; 43:100627.

PMID: 38304334 PMC: 10831731. DOI: 10.1016/j.mmcr.2024.100627.


The effects of antifungal therapy on the recurrence of aspergillus infection after pulmonary aspergilloma resection: a study protocol for a single-center, prospective, non-blind, randomized, 24-month, parallel group study.

Chen X, Zhou Y, Zhang L, Xu J, Liang S BMC Pulm Med. 2021; 21(1):335.

PMID: 34715827 PMC: 8555331. DOI: 10.1186/s12890-021-01702-4.


Monaldi cavernostomy for lung aspergillosis: A case report.

Petreanu C, Croitoru A, Gibu A, Zariosu A, Bacalbasa N, Balescu I Exp Ther Med. 2021; 22(3):957.

PMID: 34335899 PMC: 8290423. DOI: 10.3892/etm.2021.10389.